- Home
- RRGB vs ARMP Comparison
RRGB vs ARMP Comparison
Compare RRGB & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RRGB
- ARMP
- Stock Information
- Founded
- RRGB 1969
- ARMP N/A
- Country
- RRGB United States
- ARMP United States
- Employees
- RRGB N/A
- ARMP N/A
- Industry
- RRGB Restaurants
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- RRGB Consumer Discretionary
- ARMP Health Care
- Exchange
- RRGB Nasdaq
- ARMP Nasdaq
- Market Cap
- RRGB 49.0M
- ARMP 52.1M
- IPO Year
- RRGB 2002
- ARMP N/A
- Fundamental
- Price
- RRGB $5.10
- ARMP $1.95
- Analyst Decision
- RRGB Strong Buy
- ARMP Strong Buy
- Analyst Count
- RRGB 4
- ARMP 1
- Target Price
- RRGB $11.88
- ARMP $9.00
- AVG Volume (30 Days)
- RRGB 1.9M
- ARMP 624.1K
- Earning Date
- RRGB 05-29-2025
- ARMP 05-14-2025
- Dividend Yield
- RRGB N/A
- ARMP N/A
- EPS Growth
- RRGB N/A
- ARMP N/A
- EPS
- RRGB N/A
- ARMP N/A
- Revenue
- RRGB $1,248,560,000.00
- ARMP $4,699,000.00
- Revenue This Year
- RRGB $0.60
- ARMP $8.43
- Revenue Next Year
- RRGB N/A
- ARMP N/A
- P/E Ratio
- RRGB N/A
- ARMP N/A
- Revenue Growth
- RRGB N/A
- ARMP 14.24
- 52 Week Low
- RRGB $2.50
- ARMP $0.90
- 52 Week High
- RRGB $9.20
- ARMP $3.42
- Technical
- Relative Strength Index (RSI)
- RRGB 78.80
- ARMP 56.79
- Support Level
- RRGB $3.11
- ARMP $1.74
- Resistance Level
- RRGB $3.41
- ARMP $2.20
- Average True Range (ATR)
- RRGB 0.29
- ARMP 0.32
- MACD
- RRGB 0.17
- ARMP 0.04
- Stochastic Oscillator
- RRGB 78.52
- ARMP 50.32
About RRGB Red Robin Gourmet Burgers Inc.
Red Robin Gourmet Burgers Inc is a restaurant operator. The company develops, operates, and franchises casual-dining restaurants and fast-casual restaurants in North America. Its brands are Red Robin, Red Robin Gourmet Burgers, Red Robin America's Gourmet Burgers and Spirits, Red Robin Burger Works, YUMMM, Red Robin Gourmet Burgers and Brews, and Red Robin Royalty names and logos. The company's revenue consists of sales from restaurant operations, gift card breakage, franchise royalties and fees, and other miscellaneous revenue. The company has one operating and one reportable segment: restaurants.
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.